Overview

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
This study will determine the pharmacodynamic and safety of MEDITOXIN® in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Medy-Tox
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
onabotulinumtoxinA